SCHEMBL25907880

SCHEMBL25907880

CCC/N=C(/C)NCc1cccc(N2CCC(C)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT6 Q96LA8 1/20 0.43
▸ HTT P42858 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ CRHBP P24387 2/20 0.38
▸ CRHR2 Q13324 2/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ MBTD1 Q05BQ5 1/20 0.37
▸ TP53BP1 Q12888 1/20 0.37
▸ L3MBTL3 Q96JM7 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ GAA P10253 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27113243 0.78 PRMT6 (0.47) PRMT6HTTNPC1RAB9AMCL1
SCHEMBL17340934 0.72 L3MBTL3 (0.45) PRMT6HTTNPC1RAB9AMCL1
SCHEMBL8276471 0.71 L3MBTL3 (0.47) PRMT6HTTNPC1RAB9AMCL1
SCHEMBL14172860 0.69 RAB9A (0.51) PRMT6NPC1RAB9AMCL1LMNA
SCHEMBL25497793 0.69 L3MBTL3 (0.45) PRMT6NPC1RAB9AMCL1L3MBTL1
SCHEMBL12367104 0.68 PRMT6 (0.46) PRMT6NPC1RAB9AMCL1L3MBTL1
SCHEMBL28156586 0.68 PRMT6 (0.64) PRMT6LMNAROCK2ROCK1MEN1
SCHEMBL24685615 0.68 L3MBTL3 (0.45) PRMT6L3MBTL1MBTD1TP53BP1L3MBTL3
SCHEMBL13920443 0.67 PRMT6 (0.45) PRMT6HTTLMNAROCK2ROCK1
SCHEMBL22144478 0.66 SMN1; SMN2 (0.46) PRMT6NPC1RAB9AMCL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4218752-A1 MARKER FOR DETERMINING ANTI-CANCER EFFECTS OF MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION PATHWAY INHIBITOR Nanjing Shijiang Medicine Technology Co., Ltd (CN) 2023-08-02 — — EP disclosed
Send feedback